Showing results (71-80 of 199) with videos related to
Sort By:
Pageof 20
Biochemistry|November 24, 1992
Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptorK J Hwang, K E Carlson, G M Anstead, et al.Journal of Medicinal Chemistry|July 1, 1988
2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenesG M Anstead, R J Altenbach, S R Wilson, et al.Bioconjugate Chemistry|May 17, 2001
Fluorine-substituted ligands for the peroxisome proliferator-activated receptor gamma (PPARgamma): potential imaging agents for metastatic tumorsS H Kim, S D Jonson, M J Welch, et al.Journal of Medicinal Chemistry|May 1, 1983
Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicinP K Chakravarty, P L Carl, M J Weber, et al.Nuclear Medicine and Biology|April 1, 1997
Synthesis, estrogen receptor binding, and tissue distribution of [18F]fluorodoisynolic acidsA W Scribner, S D Jonson, M J Welch, et al.Journal of Medicinal Chemistry|September 1, 1980
Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogensD F Heiman, S G Senderoff, J A Katzenellenbogen, et al.The Journal of Biological Chemistry|March 25, 1981
Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptorsB S Katzenellenbogen, E J Pavlik, D W Robertson, et al.Journal of Toxicology and Environmental Health. Supplement|January 11, 1976
Chemical probes of estrogen action: affinity labelingJ A Katzenellenbogen, K E Carlson, H J Johnson, et al.Journal of Steroid Biochemistry|June 1, 1983
Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogensK D McElvany, K E Carlson, J A Katzenellenbogen, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1980
Protease-activated "prodrugs" for cancer chemotherapyP L Carl, P K Chakravarty, J A Katzenellenbogen, et al.Pageof 20